Data / Form D filings / Phi Therapeutics, Inc.
Phi Therapeutics, Inc.: Form D filings
Phi Therapeutics, Inc., a biotechnology company in Petaluma, CA, filed 4 Form D notices with the SEC between 2019 and 2024. The latest, on June 26, 2024, reports $7.7 million sold of a $7.7 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1250 PETALUMA BLVD N, Petaluma, CA, 94952
- Phone
- (707) 243-8820
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1778492
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 26, 2024 | Amendment | $7,655,830 | $7,655,830 | 22 | Mar 22, 2023 | sec.gov | |
| Apr 6, 2023 | New notice | $7,655,835 | $4,155,831 | $3,500,004 | 16 | Mar 22, 2023 | sec.gov |
| Jan 6, 2022 | New notice | $2,000,000 | $660,000 | $1,340,000 | 7 | Dec 22, 2021 | sec.gov |
| Jun 4, 2019 | New notice | $1,575,000 | $575,000 | $1,000,000 | 4 | May 24, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JUN LI | Director | |
| YUG VARMA | Executive Officer, Director | |
| NEIL GIUGNO | Executive Officer, Director | |
| KEVIN LAW | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 24, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Phi Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.